Advanced search    

Search: authors:"Amir Avan"

5 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Patient-derived osteosarcoma cells are resistant to methotrexate

Cavalcanti, Ana Cristina de Sa Lopes, Sharareh Gholamin, Amir Avan, Maria Eugenia Leite Duarte, Suzana Assad Kahn. Visualization: Mostafa Razavi, TaÂõs Hanae Kasai Brunswick. Writing ± original draft ... : Suzana Assad Kahn. Writing ± review & editing: Amanda dos Santos Cavalcanti, Walter Meohas, Gabriele de Oliveira Ribeiro, TaÂõs Hanae Kasai Brunswick, Amir Avan, João Antonio Matheus Guimarães, Maria

Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer

data by grants from Netherlands Organization for Scientific Research, NWO-Veni grant (Elisa Giovannetti), CCA Foundation 2012 (Amir Avan, Godefridus J Peters, Elisa Giovannetti), AIRC/Start-Up (Elisa

AKT1 and SELP Polymorphisms Predict the Risk of Developing Cachexia in Pancreatic Cancer Patients

(Amir Avan, Elisa Giovannetti, Godefridus J. Peters), Research Council at the Mashhad University of Medical Sciences, Mashhad (Amir Avan, Majid Ghayour-Mobarhan), Istituto Toscano Tumori (Elisa ... designed the experiments: EG PP MGM GJP. Performed the experiments: Abolfazl Avan Amir Avan MM NF TYSL. Analyzed the data: Abolfazl Avan Amir Avan MM NF TYSL EG PP MGM GJP. Contributed reagents/materials

Role of CYB5A in Pancreatic Cancer Prognosis and Autophagy Modulation

Background Loss of 18q22.3 is a prognostic marker in pancreatic ductal adenocarcinoma (PDAC). This study investigated genes encoded by this cytoband.

High-Throughput MicroRNA (miRNAs) Arrays Unravel the Prognostic Role of MiR-211 in Pancreatic Cancer

Organization for Scientific Research, VENI grant (project number 91611046 (Elisa Giovannetti)) and Stimuleringfonds Open Access (Elisa Giovannetti), CCA-VICI Foundation grant (Elisa Giovannetti, Amir Avan